Munich
Germany
3
2023-10-19
3
2025-03-04
These are the the leading inventors for applications assigned to Ketabon GmbH:
Ketabon GmbH based in Munich, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Hydroxynorketamine for the use in the treatment of depression
#2 | 2021-12-16 ✅ Patent 12,440,456 granted on 2025-10-14Oral Dosage Forms of Ketamine
#3 | 2020-04-23 ✅ Patent 11,723,883 granted on 2023-08-15Hydroxynorketamine for the use in the treatment of depression
Also check out KETABON GMBH's (Munich, Germany) applicant profile with 3 patent applications submitted.
602664 ⎘